Takeda acquires investigational coeliac therapy
The Japanese pharma giant acquired the drug based on results from a phase IIa trial, in which the drug met its primary endpoint.
Read More
Tag: coeliac
Coeliac UK, Innovate UK announce £180K research funding available
Criteria for the projects must underpin and support Coeliac UK’s top ten research priorities.
Read More
Coeliac UK and Innovate UK team up for coeliac disease solutions
Coeliac UK has combined forces with Innovate UK to drive improvements worth £750,000 in the food technology, diagnostics and digital care industries to provide help for people who need to live gluten free.
Read More
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
- Quell launches chill phase 1/2 trial for novel cartreg therapy
- Bioxytran reports positive phase 1b/2a results for antiviral ProLectin‑M
- FDA approves once‑weekly Sogroya for wider paediatric use
- SolasCure trial shows faster healing with Aurase Wound Gel
